Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 10 (2012): Issue 6 (Jun 2012)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
NCCN News
Pages: xvi–xviii
Oncology Research Program
Pages: xxxi–xxxii
The Top Five in Oncology: Where Do We Go From Here?
By:
Harold J. Burstein
Pages: 681–682
Ten Years of Progress in Renal Cell Carcinoma
By:
Eric Jonasch
and
Robert J. Motzer
Pages: 690–693
Stereotactic Radiosurgery and Bevacizumab for Recurrent Glioblastoma Multiforme
By:
Alvin R. Cabrera
,
Kyle C. Cuneo
,
James J. Vredenburgh
,
John H. Sampson
and
John P. Kirkpatrick
Pages: 695–699
Pancreatic Adenocarcinoma, Version 2.2012
Featured Updates to the NCCN Guidelines
By:
Margaret A. Tempero
,
J. Pablo Arnoletti
,
Stephen W. Behrman
,
Edgar Ben-Josef
,
Al B. Benson III
,
Ephraim S. Casper
,
Steven J. Cohen
,
Brian Czito
,
Joshua D. I. Ellenhorn
,
William G. Hawkins
,
Joseph Herman
,
John P. Hoffman
,
Andrew Ko
,
Srinadh Komanduri
,
Albert Koong
,
Wen Wee Ma
,
Mokenge P. Malafa
,
Nipun B. Merchant
,
Sean J. Mulvihill
,
Peter Muscarella II
,
Eric K. Nakakura
,
Jorge Obando
,
Martha B. Pitman
,
Aaron R. Sasson
,
Anitra Tally
,
Sarah P. Thayer
,
Samuel Whiting
,
Robert A. Wolff
,
Brian M. Wolpin
,
Deborah A. Freedman-Cass
and
Dorothy A. Shead
Pages: 703–713
Is Vertebral Augmentation the Right Choice for Cancer Patients With Painful Vertebral Compression Fractures?
By:
Ioannis D. Papanastassiou
,
Kamran Aghayev
,
James R. Berenson
,
Meic H. Schmidt
and
Frank D. Vrionis
Pages: 715–719
Neuroendocrine Tumors
By:
Matthew H. Kulke
,
Al B. Benson III
,
Emily Bergsland
,
Jordan D. Berlin
,
Lawrence S. Blaszkowsky
,
Michael A. Choti
,
Orlo H. Clark
,
Gerard M. Doherty
,
James Eason
,
Lyska Emerson
,
Paul F. Engstrom
,
Whitney S. Goldner
,
Martin J. Heslin
,
Fouad Kandeel
,
Pamela L. Kunz
,
Boris W. Kuvshinoff II
,
Jeffrey F. Moley
,
Venu G. Pillarisetty
,
Leonard Saltz
,
David E. Schteingart
,
Manisha H. Shah
,
Stephen Shibata
,
Jonathan R. Strosberg
,
Jean-Nicolas Vauthey
,
Rebekah White
,
James C. Yao
,
Deborah A. Freedman-Cass
and
Mary A. Dwyer
Pages: 724–764
Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors
By:
Natalie B. Jones
,
Manisha H. Shah
and
Mark Bloomston
Pages: 765–774
Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors: An Update
By:
Diane L. Reidy-Lagunes
Pages: 777–783
Systemic Therapy for Advanced Carcinoid Tumors: Where Do We Go From Here?
By:
A. Scott Paulson
and
Emily K. Bergsland
Pages: 785–793
Thinking Outside the Box About Screening for Ovarian Cancer: The Nose Knows!
By:
Robert J. Morgan
Pages: 795–796
Collapse
Expand
Search
Issue
Journal
[3.227.247.17]
3.227.247.17
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
